These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21483168)

  • 21. The Utility of Exercise Testing in Risk Stratification of Asymptomatic Patients With Type 1 Brugada Pattern.
    Subramanian M; Prabhu MA; Harikrishnan MS; Shekhar SS; Pai PG; Natarajan K
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):677-683. PubMed ID: 28316113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I.
    Calò L; Giustetto C; Martino A; Sciarra L; Cerrato N; Marziali M; Rauzino J; Carlino G; de Ruvo E; Guerra F; Rebecchi M; Lanzillo C; Anselmino M; Castro A; Turreni F; Penco M; Volpe M; Capucci A; Gaita F
    J Am Coll Cardiol; 2016 Mar; 67(12):1427-1440. PubMed ID: 27012403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low rate of life-threatening events and limitations in predicting invasive and noninvasive markers of symptoms in a cohort of type 1 Brugada syndrome patients: Data and insights from the GenBra registry.
    Sacilotto L; Scanavacca MI; Olivetti N; Lemes C; Pessente GD; Wulkan F; Hachul DT; Krieger JE; Pereira AC; Darrieux FCC
    J Cardiovasc Electrophysiol; 2020 Nov; 31(11):2920-2928. PubMed ID: 32870538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low risk for arrhythmic events in asymptomatic patients with drug-induced type 1 ECG. Do patients with drug-induced Brugada type ECG have poor prognosis? (Con).
    Nishizaki M; Sakurada H; Yamawake N; Ueda-Tatsumoto A; Hiraoka M
    Circ J; 2010 Nov; 74(11):2464-73. PubMed ID: 20962431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiographic characteristics of premature ventricular contractions in subjects with type 1 pattern of Brugada syndrome.
    Letsas KP; Asvestas D; Vlachos K; Karlis D; Korantzopoulos P; Efremidis M; Sideris A
    J Electrocardiol; 2014; 47(3):351-5. PubMed ID: 24636795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standard ECG in Brugada Syndrome as a Marker of Prognosis: From Risk Stratification to Pathophysiological Insights.
    Vitali F; Brieda A; Balla C; Pavasini R; Tonet E; Serenelli M; Ferrari R; Delise P; Rapezzi C; Bertini M
    J Am Heart Assoc; 2021 May; 10(10):e020767. PubMed ID: 33977759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Brugada syndrome--a rare cause of syncope and sudden death].
    Levin CG; Khalili P; Floderer E
    Lakartidningen; 2015 Nov; 112():. PubMed ID: 26660962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Ventricular Arrhythmias and Sudden Death in a Québec Cohort With Brugada Syndrome.
    Rivard L; Roux A; Nault I; Champagne J; Roux JF; Tadros R; Talajic M; Cadrin-Tourigny J; Shohoudi A; Mondésert B; Roy D; Macle L; Andrade J; Dyrda K; Dubuc M; Guerra PG; Sarrazin JF; Thibault B; Khairy P
    Can J Cardiol; 2016 Nov; 32(11):1355.e1-1355.e7. PubMed ID: 27378596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrocardiographic features of inherited diseases that predispose to the development of cardiac arrhythmias, long QT syndrome, arrhythmogenic right ventricular cardiomyopathy/dysplasia, and Brugada syndrome.
    Marcus FI
    J Electrocardiol; 2000; 33 Suppl():1-10. PubMed ID: 11265707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term prognosis in patients with non-type 1 Brugada electrocardiogram: Results from a large Japanese cohort of idiopathic ventricular fibrillation.
    Shinohara T; Takagi M; Kamakura T; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M; Aonuma K;
    Ann Noninvasive Electrocardiol; 2021 Jul; 26(4):e12831. PubMed ID: 33608945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Brugada ECG].
    Richter S
    Herzschrittmacherther Elektrophysiol; 2015 Sep; 26(3):247-59. PubMed ID: 26249049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is this a philosophic issue? Do patients with drug-induced Brugada type ECG have poor prognosis? (Pro).
    Shimizu A
    Circ J; 2010 Nov; 74(11):2455-63. PubMed ID: 20962432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QT interval greater than 460 ms in multiple electrocardiograms during follow-up in patients with Brugada syndrome: What does it contribute?
    Puga Bravo M; Castro J; Gallardo Y
    Rev Port Cardiol (Engl Ed); 2020 Apr; 39(4):183-186. PubMed ID: 32416997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome.
    Castro Hevia J; Antzelevitch C; Tornés Bárzaga F; Dorantes Sánchez M; Dorticós Balea F; Zayas Molina R; Quiñones Pérez MA; Fayad Rodríguez Y
    J Am Coll Cardiol; 2006 May; 47(9):1828-34. PubMed ID: 16682308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and long-term clinical course of patients with Brugada syndrome without previous cardiac arrest: a multiparametric risk stratification approach.
    Letsas KP; Bazoukis G; Efremidis M; Georgopoulos S; Korantzopoulos P; Fragakis N; Asvestas D; Vlachos K; Saplaouras A; Sakellaropoulou A; Mililis P; Strempelas P; Giannopoulos G; Gavrielatos G; Tzeis S; Kardamis C; Katsivas A; Deftereos S; Stavrakis S; Sideris A
    Europace; 2019 Dec; 21(12):1911-1918. PubMed ID: 31638693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporating Latent Variables Using Nonnegative Matrix Factorization Improves Risk Stratification in Brugada Syndrome.
    Tse G; Zhou J; Lee S; Liu T; Bazoukis G; Mililis P; Wong ICK; Chen C; Xia Y; Kamakura T; Aiba T; Kusano K; Zhang Q; Letsas KP
    J Am Heart Assoc; 2020 Nov; 9(22):e012714. PubMed ID: 33170070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
    Doi A; Takagi M; Maeda K; Tatsumi H; Shimeno K; Yoshiyama M
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):688-96. PubMed ID: 20050961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of T-wave alternans during night time as a predictor for ventricular fibrillation in patients with Brugada syndrome.
    Sakamoto S; Takagi M; Tatsumi H; Doi A; Sugioka K; Hanatani A; Yoshiyama M
    Heart Vessels; 2016 Jun; 31(6):947-56. PubMed ID: 25989739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.